Skip to main content

Table 2 Comorbidities of patients with rheumatoid arthritis from the CorEvitas registry included in the analyses, at baseline and during follow-up

From: Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach

 

Baseline

Year 2

Year 4

Year 6

N subjects

11,883

10,887

10,609

10,721

Total # comorbidities

22,946

26,900

29,966

33,466

 

Percentages

Mental health

41.8

51.2

55.6

59.1

Hypertension

36.4

51.8

56.4

60.4

Osteoporosis

22.7

23.3

23.3

23.4

Hyperlipidemia

9.8

10.5

11.1

11.3

Diabetes

9.5

13.6

15.6

17.1

Coronary artery disease

7.1

9.6

11.1

12.7

Acute kidney injury

7.0

10.1

13.4

16.7

NMSC

6.3

9.6

12.3

14.4

Asthma/COPD

5.5

5.8

6.3

6.7

Other cancer

5.0

6.1

7.0

8.1

Psoriasis

4.3

5.3

5.6

5.7

Fibromyalgia

3.7

6.2

10.4

12.1

Gastrointestinal bleed

3.6

3.6

3.7

3.7

Liver disease

3.4

4.0

4.0

4.3

RA Lung

2.9

3.1

3.2

3.3

Stroke/TIA

2.2

2.9

3.9

4.8

Solid tumor

2.0

2.6

3.2

3.9

DVT/PE

1.7

2.1

2.4

2.9

Melanoma

1.0

1.9

2.8

3.6

Heart failure

0.9

1.4

2.0

2.8

Arrhythmia

0.4

0.5

0.6

0.9

Demyelinating

0.4

0.5

0.5

0.5

Lymphoma

0.4

0.5

0.8

1.1

  1. DVT/PE deep venous thrombosis/pulmonary embolus, NMSC non-melanoma skin cancer, GI gastrointestinal